Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine - Wikidata - wikimedia - TriplyDB

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine

http://www.wikidata.org/entity/Q30425439

about

Advancements in the development of subunit influenza vaccines Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses Adjuvant efficacy of mOMV against avian influenza virus infection in mice.H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.Evaluation of oseltamivir prophylaxis regimens for reducing influenza virus infection, transmission and disease severity in a ferret model of household contact.Evaluation of antibody response in mice against avian influenza A (H5N1) strain neuraminidase expressed in yeast Pichia pastoris.Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.Influenza vaccines: a moving interdisciplinary field.Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs.Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.A review of the changes to the licensing of influenza vaccines in Europe.Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells.Influenza immunology evaluation and correlates of protection: a focus on vaccines.Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.Biological and protective properties of immune sera directed to the influenza virus neuraminidase.Monoclonal antibody specific to HA2 glycopeptide protects mice from H3N2 influenza virus infection Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients.Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.From Variation of Influenza Viral Proteins to Vaccine Development.Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes.Characterization of Monoclonal Antibodies against HA Protein of H1N1 Swine Influenza Virus and Protective Efficacy against H1 Viruses in Mice.Efficacy of a specific polyclonal equine F(ab')2 against avian influenza (H5N1) in ferrets: synergy with oseltamivir.The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines.H5N1 influenza vaccine induces a less robust neutralizing antibody response than seasonal trivalent and H7N9 influenza vaccines.Antibodies directed towards neuraminidase N1 control disease in a mouse model of influenza.NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development

P2860

Q27010100-4870025F-40E0-47E5-9D4D-09755C2FEBC2 Q27300233-8624BE16-58F8-4999-AFF8-CD45F879D287 Q27312788-37B5110F-819E-405F-960C-4956F1937151 Q28387782-FAA03F0E-56D8-409F-85EE-B366138B4228 Q30219688-1CEA1350-EE09-4239-BDDC-444F72057BCF Q30357273-8FCB526A-79F9-4E55-B669-4491256034DE Q30362700-12C2A503-E90B-4C47-B4DF-858716547241 Q30362744-9CD187FC-6AD1-4CC8-BE89-9D9F766AE669 Q30365079-F50557CA-0708-4A2C-9688-56F22545DB1F Q30367695-282C1539-1575-4B52-8986-9DCDE6A36B5A Q30368247-B5B730C2-AAAD-4B7A-A245-408A2C23E9C2 Q30372141-735D8D0A-03FA-42F0-ABEC-74E1EB94E13D Q30374446-6108876C-3523-4061-A85F-F963160902DE Q30379967-3AFA9BCB-4766-475C-9541-D3F5CAB9C6D7 Q30382787-2A675EDB-0DA9-437D-8C4F-4B2733B5EE6F Q30385397-8483DF8B-803A-4CD6-A2CE-C76F1037569C Q30386612-93CF7BF0-F1BA-4770-808F-37C262AE6C19 Q30386823-AB30ADBA-20C3-4222-B401-AAC04E8F121E Q30401056-459CC39E-7F9D-41EB-947C-95EF4996E593 Q30432591-6A97F325-5831-45AE-839B-7966E60BD337 Q33820732-530FFED2-78D0-47F1-A8AE-B9D5326CD9A6 Q34991399-3D294054-066B-4A39-9777-9903F02245C4 Q35190882-5A7657F1-EF2D-4E9F-B2F2-FE24D2D252B7 Q35570521-E8D42794-31DE-4D76-8B9A-1D00C68995BB Q35677624-D52D876E-0FE2-4A92-A558-59F984C600FE Q35826733-D82B91CF-062B-444B-8863-17047D7DEDED Q36227268-3C936697-C7A2-4727-BDBB-9C6E79647886 Q39441534-EE8FEE14-2980-4C0C-B2BD-41896C04930B Q40075978-5FC251F8-D8ED-40F5-8716-60195185C08B Q40091003-9924B347-2687-435F-B1BA-D2CC1DFDA3E6 Q40624917-8CFAC7E8-EA4B-4DA4-8944-DBC7686F5BD3 Q43673390-1B64148D-EF46-4FFD-B546-AE10DFE7ED2F Q47149344-9D7E7877-3130-4781-9A15-274A12DA622E Q47426452-98745FE3-8BB7-4AC9-B060-76781ABB191B Q52609074-C7754EBD-BA66-49EF-985B-E9AF1CA5D6E2 Q57093905-43E3359B-F428-4F7B-8760-BD5C8791C502 Q57094018-2FDD0E2D-DE40-4F6B-BF15-A6F3C170ED98 Q57094593-CB961E40-DE06-4DD5-8001-ED43BF207789

P2860

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine

http://www.wikidata.org/entity/Q30425439

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@ast

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@en

type

label

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@ast

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@en

prefLabel

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@ast

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@en

P1433

Q30425439-9B8BA388-5368-4F61-87C9-FBB3B7D47937

P1476

Q30425439-7790337B-6564-4846-9E62-CBCE13D23160

P2093

Q30425439-54A6F1C6-A663-4F38-AF4D-88E4A7C48A74

Q30425439-561B248E-A6A4-42B2-BE5C-E74A783FBA48

Q30425439-58FBABC2-82B3-4951-8EB0-1E378042CF06

Q30425439-75020C12-D5FA-49D9-837C-DA3BBFC81F22

Q30425439-A2C1DFC3-A527-4CF3-900F-660A74C18135

Q30425439-BAF29EE2-BE05-4C3B-BF29-77D8493B37D3

Q30425439-D812FDCC-50C9-4559-B10A-7B2B1B7B6289

Q30425439-E8FA04C9-2CBF-4DE7-881E-4B5417F7F4BD

Q30425439-F9166B03-1658-46C8-BE4E-D3CC8E89B3CF

Q30425439-FE09CC51-8E8C-429D-ACF0-503E017E12CE

P2860

Q30425439-0D419D26-61BC-41F6-AF84-2768D368CCD2

Q30425439-1DE3EEB7-9543-4D65-B9F3-DAB4F59E4604

Q30425439-1F434724-4A8B-4ADF-B337-0137D308B802

Q30425439-313A6A34-BD7D-4C19-AB0F-CDC5CBB3C89D

Q30425439-409BCC26-DE93-48FE-8408-FE12515CB80E

Q30425439-42149073-4154-40A4-9B45-CF5979022AE5

Q30425439-43393435-79CB-415C-AE88-979A61F471A4

Q30425439-457F584F-2521-49A9-9605-2AFD336E5F8C

Q30425439-4B0C41AD-8285-4734-B9C3-7E2B9C8F9324

Q30425439-4FA97A77-4CC0-4CD1-BA2A-FEDB97E962F9

P304

Q30425439-6A389420-B691-4B76-9A22-1EF972C66B0D

P31

Q30425439-8A6EE98E-FA29-4FE5-B69F-CA3E741EE519

P356

Q30425439-EA2FB95F-C24A-475D-B851-8B90CEE6DBA8

P433

Q30425439-0317DA83-E6C6-4620-9E56-7F679B8651D6

P478

Q30425439-E7165BA7-B93F-4A64-B58E-81BC5BD9EC7E

P50

Q30425439-D39845DE-15A8-4262-803C-F1F0D11333D5

P577

Q30425439-77F5AD9E-546D-45EF-9032-B8288D4430DC

P698

Q30425439-E6F4DE84-DDD6-454F-9532-4DD516BD3FD1

P921

Q30425439-3EA3ED67-FFB5-4927-B6C9-32CDCB530E5D

Q30425439-505C25D0-BE0E-4C14-916E-7F0BFE125721

P932

Q30425439-D66F9B78-1306-47DF-8271-93821CB8D8AE

P356

P1433

Journal of Virology

P1476

Neuraminidase-inhibiting antib ...... ith seasonal influenza vaccine

@en

P2093

Anatoly Kachurin

http://www.w3.org/2001/XMLSchema#string

Deborah Middleton

http://www.w3.org/2001/XMLSchema#string

Ian G Barr

http://www.w3.org/2001/XMLSchema#string

Jesse Bodle

http://www.w3.org/2001/XMLSchema#string

Jessica Klippel

http://www.w3.org/2001/XMLSchema#string

Lorena E Brown

http://www.w3.org/2001/XMLSchema#string

Martin Pearse

http://www.w3.org/2001/XMLSchema#string

Olga Kachurina

http://www.w3.org/2001/XMLSchema#string

Steven Rockman

http://www.w3.org/2001/XMLSchema#string

Sue Lowther

http://www.w3.org/2001/XMLSchema#string

P2860

Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza

Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells

Airborne transmission of influenza A/H5N1 virus between ferrets

Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets

Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization

The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic.

P304

3053-3061

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.02434-12

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Brad Gilbertson

P577

2013-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23283953

http://www.w3.org/2001/XMLSchema#string

P921

P932

3592172

http://www.w3.org/2001/XMLSchema#string